The Patent Finder

Milkhaus Laboratory, Inc.

Also on record
Records under this name other than patents Milkhaus Laboratory, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Milkhaus Laboratory, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,998,121Method of treatment of connective tissue disorders by administration of streptolysin O
Term ended
Term ended Jun 2, 2024 · USPTO record
Term endedTerm ended Jun 2, 2024USPTO record
US 7,196,058Method of treatment of conditions by administration of streptolysin O
Term ended
Term ended Jun 2, 2024 · USPTO record
Term endedTerm ended Jun 2, 2024USPTO record
US 7,629,312Method of treatment of tendonitis by administration of streptolysin O
Lapsed on the fee record
Ended Dec 8, 2021 · USPTO record
Lapsed on the fee recordEnded Dec 8, 2021USPTO record
US 6,294,171Methods for treating disease states comprising administration of low levels of antibodies
Term ended
Term ended Jan 31, 2021 · USPTO record
Term endedTerm ended Jan 31, 2021USPTO record
US 6,437,093Methods of treatment comprising administration of Substance P
Term ended
Term ended Nov 28, 2020 · USPTO record
Term endedTerm ended Nov 28, 2020USPTO record
US 6,187,309Method for treatment of symptoms of central nervous system disorders
Term ended
Term ended Feb 29, 2020 · USPTO record
Term endedTerm ended Feb 29, 2020USPTO record
US 6,436,401Methods for alleviating symptoms associated with diabetes and diabetic neuropathy comprising administration of low levels of antibodies
Term ended
Term ended Feb 29, 2020 · USPTO record
Term endedTerm ended Feb 29, 2020USPTO record
US 6,713,058Methods for alleviating symptoms associated with neuropathic conditions comprising administration of low levels of antibodies
Term ended
Ended no later than Feb 29, 2020 · USPTO record
Term endedEnded no later than Feb 29, 2020USPTO record
US 6,100,244Method for treating respiratory distress by sublingual administration of DNA
Term ended
Term ended Nov 3, 2019 · USPTO record
Term endedTerm ended Nov 3, 2019USPTO record
US 7,101,847Method of treating chronic pelvic pain syndrome by administration of chorionic gonadotropin
Lapsed on the fee record
Ended Sep 5, 2018 · USPTO record
Lapsed on the fee recordEnded Sep 5, 2018USPTO record
10 of 33 patents shown.
Pro members see all 33.
Pro members: see all 33 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited